recurrent pancreatic cancer
Showing 1 - 25 of 46
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- sorafenib tosylate
- +4 more
-
Aurora, Colorado
- +1 more
Sep 8, 2022
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Active, not recruiting
- Acinar Cell Adenocarcinoma of the Pancreas
- +3 more
- 6,8-bis(benzylthio)octanoic acid
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 22, 2021
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +3 more
- metformin hydrochloride
- +4 more
-
Cleveland, Ohio
- +1 more
Aug 9, 2021
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in Bronx
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- paclitaxel
- bryostatin 1
-
Bronx, New YorkMontefiore Medical Center
May 18, 2021
Recurrent Pancreatic Cancer Trial in Shanghai (Tislelizumab, Nab paclitaxel, Gemcitabine)
Recruiting
- Recurrent Pancreatic Cancer
- Tislelizumab
- +2 more
-
Shanghai, ChinaChanghai Hospital
May 25, 2021
Gastrinoma, Glucagonoma, Insulinoma Trial in Stanford (Capecitabine, Temozolomide, Bevacizumab)
Completed
- Gastrinoma
- +8 more
- Capecitabine
- +2 more
-
Stanford, CaliforniaStanford University Medical Center
Apr 8, 2021
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in San Francisco, Columbus
Completed
- Adenocarcinoma of the Pancreas
- +3 more
- erlotinib hydrochloride
- +2 more
-
San Francisco, California
- +1 more
Jul 29, 2020
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +3 more
- metformin hydrochloride
- stereotactic radiosurgery
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Seidman Cancer Ce
Jun 24, 2020
Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Chicago (biological,
Completed
- Duct Cell Adenocarcinoma of the Pancreas
- +3 more
- ipilimumab
- +2 more
-
Chicago, IllinoisNorthwestern University
Feb 24, 2020
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- vismodegib
- +6 more
-
Scottsdale, Arizona
- +2 more
Apr 4, 2019
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Australia, Singapore, United
Completed
- Adenocarcinoma of the Pancreas
- +2 more
- saracatinib
- +5 more
-
Scottsdale, Arizona
- +8 more
Mar 20, 2019
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- 6,8-bis(benzylthio)octanoic acid
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 26, 2018
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- oxaliplatin
- +7 more
-
La Jolla, California
- +13 more
Aug 30, 2018
Recurrent Melanoma, Recurrent Pancreatic Cancer, Recurrent Renal Cell Cancer Trial in Winston-Salem (siRNA-transfected
Completed
- Recurrent Melanoma
- +11 more
- siRNA-transfected peripheral blood mononuclear cells APN401
- laboratory biomarker analysis
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jul 2, 2018
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +7 more
- dasatinib
- +5 more
-
Alhambra, California
- +16 more
Jan 5, 2018
Adenocarcinoma of the Pancreas, Pancreatic Cancer, Recurrent Pancreatic Cancer Trial in Toronto (eribulin mesylate)
Completed
- Adenocarcinoma of the Pancreas
- +5 more
- eribulin mesylate
-
Toronto, Ontario, CanadaUniversity Health Network-Princess Margaret Hospital
Sep 19, 2017
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Advanced Adult Primary Liver Cancer Trial in Nashville (cetuximab,
Completed
- Adenocarcinoma of the Colon
- +66 more
- cetuximab
- +2 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Sep 28, 2015
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in United States (vismodegib,
Completed
- Adenocarcinoma of the Pancreas
- +2 more
- vismodegib
- +2 more
-
Beverly Hills, California
- +25 more
Jul 20, 2015
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Cleveland (dasatinib,
Completed
- Adenocarcinoma of the Pancreas
- +2 more
- dasatinib
- +2 more
-
Cleveland, OhioCase Western Reserve University
Apr 14, 2015
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage I Pancreatic Cancer Trial (bevacizumab, gemcitabine HCl,
Withdrawn
- Adenocarcinoma of the Pancreas
- +4 more
- bevacizumab
- +11 more
- (no location specified)
Apr 27, 2015
Recurrent Colon Cancer, Extensive Stage Small Cell Lung Cancer, Stage III Pancreatic Cancer Trial run by the NCI (Detox-B
Completed
- Recurrent Colon Cancer
- +13 more
- Detox-B adjuvant
- ras peptide cancer vaccine
-
Bethesda, MarylandMedicine Branch
Apr 27, 2015
Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Buffalo (dovitinib
Withdrawn
- Duct Cell Adenocarcinoma of the Pancreas
- +4 more
- dovitinib lactate
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 8, 2015
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Aurora, Denver, Baltimore
Completed
- Adenocarcinoma of the Pancreas
- +2 more
- gamma-secretase/Notch signalling pathway inhibitor RO4929097
-
Aurora, Colorado
- +2 more
Nov 19, 2014
Intraductal Papillary Mucinous Tumor of the Pancreas, Recurrent Pancreatic Cancer, Stage IA Pancreatic Cancer Trial in Orange
Terminated
- Intraductal Papillary Mucinous Neoplasm of the Pancreas
- +6 more
- erlotinib hydrochloride
- +6 more
-
Orange, CaliforniaUniversity of California Medical Center At Irvine-Orange Campus
Oct 7, 2014
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Rochester (gemcitabine HCl,
Completed
- Adenocarcinoma of the Pancreas
- +2 more
- gemcitabine hydrochloride
- tanespimycin
-
Rochester, MinnesotaMayo Clinic
Jul 23, 2014